Evaluating the consistency of brain-wide maps of gray matter volume and cortical thickness differences obtained for each of 59 study sites of five psychiatric disorders indicates that current widespread practices in structural MRI are unlikely to identify robust morphometric phenotypes for psychiatric disorders.
Abstract
Decades of structural magnetic resonance imaging (MRI) studies have documented alterations of gray matter morphometry in psychiatric disorders, but the field has failed to identify any consensus disease phenotypes. Here we examine whether current approaches will ever converge on such phenotypes by evaluating the consistency of brain-wide maps of gray matter volume and cortical thickness differences obtained for each of 59 study sites of five psychiatric disorders (schizophrenia, schizoaffective disorder, autism spectrum disorder, major depressive disorder and bipolar disorder), totaling 2,437 patients and 2,065 controls. We find that cross-site consistency is low (median r ≤ 0.16); markedly reduced compared to Alzheimer’s disease (r = 0.54); unexplained by demographic, clinical or scanner differences; and robust to analytic choices. Using bootstrapping, we observe that consistency may improve for sample sizes ≥200 per group for schizophrenia but that other disorders may require much larger samples. Our findings indicate that current widespread practices in structural MRI are unlikely to identify robust morphometric phenotypes for psychiatric disorders. A large analysis of MRI studies in five psychiatric disorders reveals that maps of brain volume differences in psychiatric illness are rarely reproducible, highlighting the need for alternative approaches to biomarker discovery.
BACKGROUND
Previous studies have reported gray matter volume (GMV) deficits in different illness stages of depression; however, whether patients at different stages show shared or distinct GMV abnormality patterns has not been systematically characterized.
METHODS
We conducted a quantitative voxel-wise meta-analysis...
Kun Xu, Bao-Lin Wu, Zi-Ru Zhao et al.· Journal of Affective Disorde...· 0 citations
It is suggested that normative references of the amygdala subfields provide insights into cross-disease alteration patterns and offer potential neuroimaging biomarkers to aid differential diagnosis and clinical assessment.
Chao Zhang, Lu Bai, Dong-Li Shi et al.· Neuroscience Bulletin· 0 citations
BACKGROUND
Autism is characterized by heterogeneity in clinical characteristics, neuroimaging and genetic profiles. To elucidate the multi-level heterogeneity, Buch et al. (2023) identified biologically meaningful subgroups in Autism Brain Imaging Data Exchange (ABIDE). However, ABIDE contains non-biological sources of...
Dong-Yue Zhou, T. Mei, M. Oldehinkel et al.· Biological Psychiatry: Cogni...· 1 citation